Adamas Pharmaceuticals
ADMS
#7089
Rank
โ‚น31.62 B
Marketcap
โ‚น690.63
Share price
0.00%
Change (1 day)
16,485.23%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚น6.51 Billion

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚น7.40 Billion. In 2020 the company made a revenue of โ‚น6.25 Billion an increase over the revenue in the year 2019 that were of โ‚น4.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น6.51 B4.09%
2020โ‚น6.25 B36.28%
2019โ‚น4.59 B60.48%
2018โ‚น2.86 B
2016โ‚น48.05 M-70.15%
2015โ‚น0.16 B-96.57%
2014โ‚น4.69 B-21.45%
2013โ‚น5.97 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น6.86 B-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น52.94 B 614.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.620 T 62,266.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.315 T 44,652.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น5.249 T 70,746.70%๐Ÿ‡บ๐Ÿ‡ธ USA